172 related articles for article (PubMed ID: 38519049)
21. Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practice.
Bucsics T; Schoder M; Goeschl N; Schwabl P; Mandorfer M; Diermayr M; Feldner M; Riedl F; Bauer D; Angermayr B; Cejna M; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Karner J; Karnel F; Reiberger T
Dig Liver Dis; 2017 Dec; 49(12):1360-1367. PubMed ID: 28869158
[TBL] [Abstract][Full Text] [Related]
22. Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices: study protocol for a randomised controlled trial.
Patel VC; McPhail MJ; Uddin R; Jafari H; Lawrence V; Le Boutillier C; Shearer J; Yaziji N; Cape A; Ahmed H; Ward C; Walsh P; Besly K; Zamalloa A; Kelly J; ; Carter B
Trials; 2024 Apr; 25(1):265. PubMed ID: 38627804
[TBL] [Abstract][Full Text] [Related]
23. Model for end-stage liver disease score and hemodynamic instability as a predictor of poor outcome in early transjugular intrahepatic portosystemic shunt treatment for acute variceal hemorrhage.
Hermie L; Dhondt E; Vanlangenhove P; Hoste E; Geerts A; Defreyne L
Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1441-1446. PubMed ID: 30048333
[TBL] [Abstract][Full Text] [Related]
24. Diastolic dysfunction on echocardiography does not predict survival after transjugular intrahepatic portosystemic stent-shunt in patients with cirrhosis.
Armstrong MJ; Gohar F; Dhaliwal A; Nightingale P; Baker G; Greaves D; Mangat K; Zia Z; Karkhanis S; Olliff S; Mehrzad H; Steeds RP; Tripathi D
Aliment Pharmacol Ther; 2019 Mar; 49(6):797-806. PubMed ID: 30773660
[TBL] [Abstract][Full Text] [Related]
25. The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations.
Tripathi D; Therapondos G; Jackson E; Redhead DN; Hayes PC
Gut; 2002 Aug; 51(2):270-4. PubMed ID: 12117893
[TBL] [Abstract][Full Text] [Related]
26. Transjugular intrahepatic portosystemic shunt with or without gastro-oesophageal variceal embolisation for the prevention of variceal rebleeding: a randomised controlled trial.
Lv Y; Chen H; Luo B; Bai W; Li K; Wang Z; Xia D; Guo W; Wang Q; Li X; Yuan J; Cai H; Xia J; Yin Z; Fan D; Han G
Lancet Gastroenterol Hepatol; 2022 Aug; 7(8):736-746. PubMed ID: 35588750
[TBL] [Abstract][Full Text] [Related]
27. Randomised clinical trial: standard of care versus early-transjugular intrahepatic porto-systemic shunt (TIPSS) in patients with cirrhosis and oesophageal variceal bleeding.
Dunne PDJ; Sinha R; Stanley AJ; Lachlan N; Ireland H; Shams A; Kasthuri R; Forrest EH; Hayes PC
Aliment Pharmacol Ther; 2020 Jul; 52(1):98-106. PubMed ID: 32452561
[TBL] [Abstract][Full Text] [Related]
28. A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage.
Jalan R; John TG; Redhead DN; Garden OJ; Simpson KJ; Finlayson ND; Hayes PC
Am J Gastroenterol; 1995 Nov; 90(11):1932-7. PubMed ID: 7484994
[TBL] [Abstract][Full Text] [Related]
29. Impact of transjugular intrahepatic portosystemic stent-shunt for secondary prophylaxis of oesophageal variceal haemorrhage: a single-centre study over an 11-year period.
Jalan R; Bzeizi KI; Tripathi D; Lui HF; Redhead DN; Hayes PC
Eur J Gastroenterol Hepatol; 2002 Jun; 14(6):615-26. PubMed ID: 12072595
[TBL] [Abstract][Full Text] [Related]
30. Association of nonmalignant portal vein thrombosis and clinical outcomes in patients with cirrhosis and acute variceal bleeding: a multicenter observational study.
Lv Y; Bai W; Zhu X; Xue H; Zhao J; Zhuge Y; Sun J; Zhang C; Ding P; Jiang Z; Zhu X; Ren W; LiZhang YK; Zhang W; Li K; Wang Z; Luo B; Li X; Yuan J; Yang Z; Guo W; Xia D; Xie H; Yang C; Pan Y; Yin Z; Fan D; Han G
Hepatol Int; 2023 Oct; 17(5):1192-1204. PubMed ID: 37258989
[TBL] [Abstract][Full Text] [Related]
31. Current approaches to the management of patients with liver cirrhosis who have acute esophageal variceal bleeding.
Garbuzenko DV
Curr Med Res Opin; 2016; 32(3):467-75. PubMed ID: 26804426
[TBL] [Abstract][Full Text] [Related]
32. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
Colombato L
J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
[TBL] [Abstract][Full Text] [Related]
33. Small-Diameter Transjugular Intrahepatic Portosystemic Shunt versus Endoscopic Variceal Ligation Plus Propranolol for Variceal Rebleeding in Advanced Cirrhosis.
Wang X; Liu G; Wu J; Xiao X; Yan Y; Guo Y; Yang J; Li X; He Y; Yang L; Luo X
Radiology; 2023 Aug; 308(2):e223201. PubMed ID: 37606572
[TBL] [Abstract][Full Text] [Related]
34. Liver transplantation in patients with transjugular intrahepatic portosystemic shunts.
Chui AK; Rao AR; Waugh RC; Mayr M; Verran DJ; Koorey D; McCaughan GW; Ong J; Sheil AG
Aust N Z J Surg; 2000 Jul; 70(7):493-5. PubMed ID: 10901576
[TBL] [Abstract][Full Text] [Related]
35. A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices.
Jalan R; Forrest EH; Stanley AJ; Redhead DN; Forbes J; Dillon JF; MacGilchrist AJ; Finlayson ND; Hayes PC
Hepatology; 1997 Nov; 26(5):1115-22. PubMed ID: 9362350
[TBL] [Abstract][Full Text] [Related]
36. Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial).
de Wit K; Schaapman JJ; Nevens F; Verbeek J; Coenen S; Cuperus FJC; Kramer M; Tjwa ETTL; Mostafavi N; Dijkgraaf MGW; van Delden OM; Beuers UHW; Coenraad MJ; Takkenberg RB
BMJ Open Gastroenterol; 2020 Dec; 7(1):. PubMed ID: 33372103
[TBL] [Abstract][Full Text] [Related]
37. Transjugular intrahepatic portosystemic shunt treatment of variceal bleeding in an unselected patient population.
Rosenqvist K; Sheikhi R; Nyman R; Rorsman F; Sangfelt P; Ebeling Barbier C
Scand J Gastroenterol; 2018 Jan; 53(1):70-75. PubMed ID: 28990812
[TBL] [Abstract][Full Text] [Related]
38. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.
Sauerbruch T; Mengel M; Dollinger M; Zipprich A; Rössle M; Panther E; Wiest R; Caca K; Hoffmeister A; Lutz H; Schoo R; Lorenzen H; Trebicka J; Appenrodt B; Schepke M; Fimmers R;
Gastroenterology; 2015 Sep; 149(3):660-8.e1. PubMed ID: 25989386
[TBL] [Abstract][Full Text] [Related]
39. Multicenter External Validation of Risk Stratification Criteria for Patients With Variceal Bleeding.
Conejo I; Guardascione MA; Tandon P; Cachero A; Castellote J; Abraldes JG; Amitrano L; Genescà J; Augustin S
Clin Gastroenterol Hepatol; 2018 Jan; 16(1):132-139.e8. PubMed ID: 28501536
[TBL] [Abstract][Full Text] [Related]
40. Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS.
Trebicka J; Gu W; Ibáñez-Samaniego L; Hernández-Gea V; Pitarch C; Garcia E; Procopet B; Giráldez Á; Amitrano L; Villanueva C; Thabut D; Silva-Junior G; Martinez J; Genescà J; Bureau C; Llop E; Laleman W; Palazon JM; Castellote J; Rodrigues S; Gluud L; Ferreira CN; Barcelo R; Cañete N; Rodríguez M; Ferlitsch A; Mundi JL; Gronbaek H; Hernández-Guerra M; Sassatelli R; Dell'Era A; Senzolo M; Abraldes JG; Romero-Gómez M; Zipprich A; Casas M; Masnou H; Primignani M; Weiss E; Catalina MV; Erasmus HP; Uschner FE; Schulz M; Brol MJ; Praktiknjo M; Chang J; Krag A; Nevens F; Calleja JL; Robic MA; Conejo I; Albillos A; Rudler M; Alvarado E; Guardascione MA; Tantau M; Bosch J; Torres F; Pavesi M; Garcia-Pagán JC; Jansen C; Bañares R;
J Hepatol; 2020 Nov; 73(5):1082-1091. PubMed ID: 32339602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
